He still holds over 522,000 shares (over $30.2 million, at current prices) — down only slightly from an all time high of over 550,000 shares.
[In addition, Mirian Graddick-Weir, the lead Human Resources EVP level C-suite executive at Merck, exercised and sold about 45,000 shares under a trading plan — but still holds over 87,000 shares, post those sales — or about $5.1 million overall.]
Here is the bit from Mr. Frazier’s SEC Form 4 filed this afternoon:
. . . .522,477.063 Securities Beneficially Owned Following Reported Transaction. . . .
That’s a wrap for this particular evening. . . smile.